Why are you testing your baby?
The test tube baby has a special place in the world of testing.
A child who is not tested is not guaranteed a healthy life, so it is important to make sure they are well cared for and not put at risk.
The latest test tube results are being released by the National Institute for Health and Care Excellence (NICE), which is leading the drive for the testing of babies born with the genetic condition known as Duchenne muscular dystrophy (DMD).
As the name suggests, the disorder affects muscles in the neck, shoulders and upper back.
The condition causes muscular weakness and weakness in muscles in other parts of the body, such as the hands and feet.
While the disorder is often diagnosed in children who have been born to mothers who suffer from the disease, there is no cure for Duchenna muscular dystonia.
In addition to genetic testing, NICE will also be looking at ways to improve the health of infants and children who suffer with the condition.
“If we can find ways to help children who are suffering, and we can prevent these kids from suffering, then we can save lives,” said Helen Fisher, head of research at the Royal College of Obstetricians and Gynaecologists (RCOG).
Currently, Duchennie muscular dystroke sufferers can only receive genetic testing if they are in a specialised group that has been approved by NICE and receive the following conditions:a child born with at least one of the following:DMD is diagnosed in one-third of children with DMD, and is the most common genetic condition in the UK.
Children diagnosed with Dmd may have mild or moderate symptoms, including weakness, fever, sore throat and difficulty breathing.
If this is the case, a specialist can also be called in to check if the child has any underlying health problems.
A child diagnosed with Duchennemis muscular dystrophies is usually diagnosed when they are about 18 months old.
If the child’s symptoms do not improve within six weeks, they may need to be seen in a specialist.NICE is working with GP surgeries and other health care providers to test and diagnose children as young as three years old.NICHE will also introduce a new, simpler way for parents to share the results of their child’s genetic tests with doctors and other healthcare providers.
For children who test positive, parents will be able to access a digital QR code on their mobile phone that will allow them to send the results to the National Duchennecological Society (NDSS) to help researchers identify the child.
Parents will also have the option to share with their GP whether they are happy with the results and whether their child is doing well, with the hope that more children may benefit.
NICE has also launched a digital version of its test-sheet app, which will help families make sure their child has been well and will be tested for Duchene muscular dysthrophy in the future.
Since its launch, NICHE has also announced it is working to ensure that genetic tests are carried out in more GP surgeries, so that more families can have their child tested.
As of April 2019, over 2.6 million children and young people have been diagnosed with the disease.
Read more about Duchennee muscular dysteres syndrome: Read More